Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Ascletis, Astrazeneca, Beigene, China Oncology Focus, Clarity, Daewoong, Eccogene, Effector, Entasis, GNT Biotech & Medicals, Hutchmed, Kintor, Lee’s Pharmaceutical Holdings, Newsoara, Palisade, RDIF, Sorrento, Trevena, Zai Lab.